Analysts say that despite OAI on Eugia unit-III, Aurobindo Pharma’s Vizag facility may play a back up for unit-III and for new ANDA filings contributing to growth in FY26
Subscribe To Our Free Newsletter |
Analysts say that despite OAI on Eugia unit-III, Aurobindo Pharma’s Vizag facility may play a back up for unit-III and for new ANDA filings contributing to growth in FY26
Subscribe To Our Free Newsletter |
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!